Docetaxel (Sandoz Inc)
Welcome to the PulseAid listing for the Docetaxel drug offered from Sandoz Inc. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | docetaxel |
SUBSTANCE NAME: | DOCETAXEL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2011-06-29 |
END MARKETING DATE: | 0000-00-00 |
Docetaxel HUMAN PRESCRIPTION DRUG Details:
Item Description | Docetaxel from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 2011-06-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 66758-050_8013c462-2679-43e9-8227-f9a52db0450a |
PRODUCT NDC: | 66758-050 |
APPLICATION NUMBER: | NDA201525 |
Other DOCETAXEL Pharmaceutical Manufacturers / Labelers: